Related Experiment Videos
Genetics of osteoporosis
1University of Aberdeen Medical School, Department of Medicine and Therapeutics, University of Aberdeen, AB25 2ZD, UK.
Current Rheumatology Reports
|March 12, 2005
Summary
Genetic factors significantly influence bone mineral density and osteoporosis risk. Identifying causal genes advances fracture risk assessment and novel osteoporosis drug development.
Area of Science:
- Genetics
- Bone Biology
- Osteoporosis Research
Background:
- Genetic factors are crucial in determining bone mineral density (BMD) and osteoporosis-related traits.
- Linkage studies have identified quantitative trait loci for BMD regulation, but causal genes remain largely unknown.
- Research into monogenic bone diseases is revealing genes whose polymorphisms may influence population BMD.
Purpose of the Study:
- To review the role of genetic factors in bone health and osteoporosis.
- To highlight progress in identifying genes associated with bone density and disease.
- To explore the potential for genetic discoveries in developing new diagnostic markers and therapeutic targets for osteoporosis.
Main Methods:
- Review of genetic linkage studies in humans and mice.
- Analysis of genetic factors identified in monogenic bone diseases.
- Examination of the impact of gene polymorphisms on bone mineral density in the general population.
Main Results:
- Genetic factors significantly impact bone mineral density, skeletal geometry, and bone turnover.
- While many quantitative trait loci are known, few causal genes for BMD regulation have been identified.
- Polymorphisms in genes causing monogenic bone diseases are implicated in regulating BMD in the general population.
Conclusions:
- Understanding the genetic basis of osteoporosis is advancing rapidly.
- Genetic insights offer potential for developing novel biomarkers for fracture risk assessment.
- Identifying genetic targets holds promise for new pharmacological treatments for osteoporosis.